176 related articles for article (PubMed ID: 19275543)
1. The role of the RhoA/rho-kinase pathway in pulmonary hypertension.
Nossaman BD; Kadowitz PJ
Curr Drug Discov Technol; 2009 Mar; 6(1):59-71. PubMed ID: 19275543
[TBL] [Abstract][Full Text] [Related]
2. Role of the RhoA/Rho-kinase pathway in the regulation of pulmonary vasoconstrictor function.
Nossaman BD; Nossaman VE; Murthy SN; Kadowitz PJ
Can J Physiol Pharmacol; 2010 Jan; 88(1):1-8. PubMed ID: 20130732
[TBL] [Abstract][Full Text] [Related]
3. RhoA/Rho-Kinase in the Cardiovascular System.
Shimokawa H; Sunamura S; Satoh K
Circ Res; 2016 Jan; 118(2):352-66. PubMed ID: 26838319
[TBL] [Abstract][Full Text] [Related]
4. RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.
Barman SA; Zhu S; White RE
Vasc Health Risk Manag; 2009; 5():663-71. PubMed ID: 19707285
[TBL] [Abstract][Full Text] [Related]
5. Rho kinase-mediated vasoconstriction in pulmonary hypertension.
McMurtry IF; Abe K; Ota H; Fagan KA; Oka M
Adv Exp Med Biol; 2010; 661():299-308. PubMed ID: 20204738
[TBL] [Abstract][Full Text] [Related]
6. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
[TBL] [Abstract][Full Text] [Related]
7. RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
Guilluy C; Eddahibi S; Agard C; Guignabert C; Izikki M; Tu L; Savale L; Humbert M; Fadel E; Adnot S; Loirand G; Pacaud P
Am J Respir Crit Care Med; 2009 Jun; 179(12):1151-8. PubMed ID: 19299501
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase G-I deficiency induces pulmonary hypertension through Rho A/Rho kinase activation.
Zhao YD; Cai L; Mirza MK; Huang X; Geenen DL; Hofmann F; Yuan JX; Zhao YY
Am J Pathol; 2012 Jun; 180(6):2268-75. PubMed ID: 22632818
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the RhoA/Rho-associated, coiled-coil-containing protein kinase-1 pathway is involved in the therapeutic effects of simvastatin on pulmonary arterial hypertension.
Liu WH; Xu XH; Luo Q; Zhang HL; Wang Y; Xi QY; Zhao ZH; Liu ZH
Clin Exp Hypertens; 2018; 40(3):224-230. PubMed ID: 29319354
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.
Homma N; Nagaoka T; Morio Y; Ota H; Gebb SA; Karoor V; McMurtry IF; Oka M
J Cardiovasc Pharmacol; 2007 Dec; 50(6):697-702. PubMed ID: 18091588
[TBL] [Abstract][Full Text] [Related]
12. [Expression and activity of RhoA/Rho kinase in remodeling of high blood flow pulmonary vessels.].
Li FH; Xia W; Sun RP
Zhonghua Er Ke Za Zhi; 2007 May; 45(5):387-92. PubMed ID: 17697629
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin attenuates involvement of RhoA/Rho-kinase pathway and NF-κB activation in hypoxic pulmonary hypertensive rats.
Zhang Y; Dai L; Wu S; Chen P; Zhao S
Chin Med J (Engl); 2014; 127(5):869-72. PubMed ID: 24571879
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species and RhoA signaling in vascular smooth muscle: role in chronic hypoxia-induced pulmonary hypertension.
Resta TC; Broughton BR; Jernigan NL
Adv Exp Med Biol; 2010; 661():355-73. PubMed ID: 20204742
[TBL] [Abstract][Full Text] [Related]
15. Rho kinase inhibitors: potential treatments for diabetes and diabetic complications.
Zhou H; Li YJ
Curr Pharm Des; 2012; 18(20):2964-73. PubMed ID: 22571664
[TBL] [Abstract][Full Text] [Related]
16. Rho-kinase: important new therapeutic target in cardiovascular diseases.
Satoh K; Fukumoto Y; Shimokawa H
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H287-96. PubMed ID: 21622831
[TBL] [Abstract][Full Text] [Related]
17. A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate.
Baek I; Jeon SB; Kim J; Seok YM; Song MJ; Chae SC; Jun JE; Park WH; Kim IK
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):256-61. PubMed ID: 18986333
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension.
Oka M; Fagan KA; Jones PL; McMurtry IF
Br J Pharmacol; 2008 Oct; 155(4):444-54. PubMed ID: 18536743
[TBL] [Abstract][Full Text] [Related]
19. Activation of cold-sensing transient receptor potential melastatin subtype 8 antagonizes vasoconstriction and hypertension through attenuating RhoA/Rho kinase pathway.
Sun J; Yang T; Wang P; Ma S; Zhu Z; Pu Y; Li L; Zhao Y; Xiong S; Liu D; Zhu Z
Hypertension; 2014 Jun; 63(6):1354-63. PubMed ID: 24637663
[TBL] [Abstract][Full Text] [Related]
20. Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.
Antoniu SA
Expert Opin Ther Targets; 2012 Apr; 16(4):355-63. PubMed ID: 22449260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
